Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions.
Purpose: Remdesivir, a drug originally developed against Ebola virus, is currently recommended for patients hospitalized with coronavirus disease of 2019 (COVID-19). In spite of United States Food and Drug Administration's recent assent of remdesivir as the only approved agent for COVID-19, there is...
| Published in: | Journal of Pharmacy & Pharmaceutical Sciences Vol. 24; pp. 277 - 292 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Published: |
Frontiers Media S.A.
2021
|
| Online Access: | View this record in EBSCOhost |